Limited coverage criteria – mercaptopurine

Last updated on March 19, 2025

Special Authority requests can now be submitted online. It's simple and quick!

Generic name	mercaptopurine

Special Authority criteria	Approval period
For treatment of patients with a diagnosis of: Ulcerative colitis OR Autoimmune hepatitis OR Inflammatory bowel disease OR Crohn's disease	Indefinite

Special Authority criteria

Approval period

For treatment of patients with a diagnosis of:

Ulcerative colitis

Autoimmune hepatitis

Inflammatory bowel disease

Crohn's disease

Indefinite

Practitioner exemptions

None

Special notes

For any cancer-related condition, please contact the British Columbia Cancer Agency at (604) 877-6098 ext. 4610

Special Authority request form(s)

Log in to eForms
HLTH 5328 – General Special Authority request (PDF, 656KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics